As the popularity of the beauty supplement biotin has grown, so has the incidence of this vitamin interfering with critical medical tests. A review published today in AACC’s The Journal of Applied Laboratory Medicine gives expert recommendations to healthcare providers on how to reduce biotin interference with test results to ensure that the many patients taking this supplement receive accurate diagnoses and treatment.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Susan Medick has been named chief financial officer (CFO) for the association, effective today.
Akatsuki Technology Co Ltd is a Japanese company, http://www.akatsuki-tech.com, which is specified in designation & making "Ultra-High-Precision Optical glass components".
AACC is pleased to announce that Wall Street Journal investigative reporter John Carreyrou will speak about his investigations into the laboratory medicine industry at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo.
A study in AACC’s The Journal of Applied Laboratory Medicine has for the first time established female-specific reference ranges for several biological variables that play key roles in thrombosis—or blood clotting—during pregnancy. This research could help lower the high U.S. maternal death rate by enabling more precise identification of pregnant women at risk for thrombosis-related complications such as preeclampsia.
Jenoptik, an industry leader in high performance optical systems and healthcare & industry solutions, is pleased to announce the opening of a West Coast office to enhance customer proximity and leverage growth in the US.
New York USA. Finger Lakes Instrumentation is pleased to introduce the Kepler KL400 cooled sCMOS camera; ideal for hyper-spectral imaging, orbital debris detection, super resolution microscopy, astronomy, and quantum imaging.
New York USA. Finger Lakes Instrumentation is pleased to introduce the Signa line of industrial filter wheels; Ideal for machine inspection, LCD inspection and OEM applications.
NovoPath, Inc. announces the integration of the NovoPathTM Anatomic Pathology Software Platform with Philips IntelliSite Pathology Solution and Wholeslide Imaging System.
WASHINGTON – AACC has issued a new guideline detailing how healthcare providers can use laboratory tests to manage treatment of pain and prevent prescription drug overdoses. Especially relevant in light of the worsening opioid epidemic, the guideline emphasizes increased collaboration between clinicians and laboratory experts as well as the use of more precise drug tests as key to identifying pain patients who are abusing their opioid prescriptions.
A first-of-its-kind study published in the Pain Management issue of AACC’s The Journal of Applied Laboratory Medicine shows that a new drug testing approach dramatically improves detection of illicit benzodiazepine use. This could help to curb abuse of these drugs, which are second only to opioids as a cause of prescription drug overdose deaths in the U.S.
Innovative research published in the Obesity issue of AACC’s journal, Clinical Chemistry, demonstrates that people are at greater risk for obesity if they produce higher than normal levels of insulin after eating processed carbohydrates. These findings support the still controversial theory that refined carbs are driving the obesity epidemic.
A special issue of AACC’s The Journal of Applied Laboratory Medicine, “Laboratory Support of Pain Management,” features groundbreaking new drug tests that could reverse the staggering climb of prescription drug overdoses in the U.S.
Laboratory medicine experts are using genomics, metabolomics, and other cutting-edge clinical testing methods to advance the understanding of obesity. A special issue of AACC’s journal Clinical Chemistry, “Obesity: Innovative Approaches to Overcome Obstacles,” highlights the latest innovations in the field that could lead to more effective public health policies to curb this epidemic.
Lab Tests Online, AACC’s award-winning public resource on laboratory testing, is pleased to announce that it has launched a dynamic redesign of labtestsonline.org to better help patients, caregivers, and medical professionals understand the many lab tests that are an integral part of healthcare.
As the use of non-invasive prenatal screening (NIPS) grows, there has been concern within the medical community that a poor understanding of this technique among clinicians and patients could negatively impact pregnancies. A review published today in AACC’s The Journal of Applied Laboratory Medicine gives an expert overview of NIPS’s many nuances, to arm healthcare providers with the information they need to ensure patients benefit from this revolutionary but complex technology.
Today, AACC sent a letter to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s proposed 2018 rates for clinical test reimbursement under the Protecting Access to Medicare Act (PAMA). In its statement, AACC expresses concern that the new payment rates could significantly limit patient access to crucial medical tests, and urges CMS to revise the rates in order to preserve high quality healthcare.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that Carmen L. Wiley, PhD, DABCC, FACB, has been elected to serve on the AACC Board of Directors as president-elect starting in January 2018.
By enabling early disease detection and personalized treatment, laboratory tests can save lives as well as billions in medical costs each year. Join AACC and leading experts in laboratory medicine for a discussion of how clinical tests can be leveraged to achieve these goals, as well as the policies needed to support testing’s vital contribution to healthcare.
Attendance at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo reached a record high at this year’s conference in San Diego. Held from July 30-August 3, the meeting featured groundbreaking advances in diagnostic research and technology that will solve a broad range of challenging patient health problems.
Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, announces the launch of recombinant Luteinizing Hormone (LH), which expands the company’s Critical Raw Material offerings.
A team of researchers has demonstrated that children with autism spectrum disorder have a unique composition of gut bacteria and urinary metabolites compared with unaffected children. The research, revealed today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego, could lead to promising new treatment options for children with autism as well as earlier detection of the disorder.
Researchers have discovered new methods that could improve treatment for infectious diseases by enabling earlier detection of influenza outbreaks and curtailing inappropriate antibiotic usage. The findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
A new study has discovered that two microRNAs could be used to develop the first-ever blood test for kidney cancer as well as novel treatments for this condition. These findings were presented today at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
A new study shows that a change in policy placing more restrictions on all hydrocodone-containing drugs has successfully decreased the use of certain opioids such as Vicodin. This research and a second study illuminating regional drug use trends in Canada were announced today at the 69th AACC Annual Scientific Meeting in San Diego, and could help to guide future strategies for combatting addiction.
Researchers have shown that a new genetic test could potentially help stem the tide of the opioid epidemic by predicting which patients are at risk of abusing prescription opioids. These findings were presented for the first time at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego.
AACC is pleased to announce the recipients of the AACC 2017 Top Corporate Supporter Awards. This year, AACC recognizes 46 different companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced a strategic relationship with B·R·A·H·M·S GmbH, part of Thermo Fisher Scientific Inc., to develop the B·R·A·H·M·S PCT (procalcitonin) assay for use on Ortho’s VITROS® Systems.
Currier Plastics provides innovative custom molding solutions that create powerful advantages for your business. Our design and engineering expertise combined with the right cost and precise time to market manufacturing provide integrated solutions to improve your business performance.
BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has expanded its infectious disease-state portfolio to include frozen whole blood, plasma and serum samples from patients with HIV-1, HIV-2, dengue, zika and malaria infection.
Medica Corporation has announced the expanded capability of its EasyRA® clinical chemistry analyzer to now provide drugs of abuse urine screening (DAU). No hardware nor software updates are required, and the added functionality will benefit both current owners and new customers.
Diener Precision Pumps, the leading manufacturer of precision piston pumps and gear pumps announces the introduction of a new enhanced Precision Series piston pump at the AACC this year in San Diego.
DWK Life Sciences, having successfully completed the integration of three industry-leading brands into a single, unified international brand, DURAN WHEATON KIMBLE (DWK), is proud to offer the diagnostics industry a convenient, reliable, and complete solution for developing and producing IVD diagnostic kits. Combining our expertise in leak-resistant plastic containers, dropping bottles and closures, diagnostic vials and other innovative packaging solutions with our capabilities in bar coding, particulate cleaning, sterile processing, and an in-house quality control team, DWK Life Sciences offers everything you need to simplify your supply chain for IVD production.
SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz™ System
SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch of the first fully integrated LC-MS system for clinical diagnostics, the SCIEX Topaz™ System.
AACC announced today that it will launch a new laboratory medicine conference and expedition next spring – AACC Middle East. AACC Middle East will showcase AACC’s globally-renowned education and scientific programs paired with a dynamic exposition in Abu Dhabi, United Arab Emirates (UAE), March 22-24, 2018.
At the 69th AACC Annual Scientific Meeting & Clinical Lab Expo—the premier global conference and exhibit for laboratory medicine—visionaries in the field will illuminate the pioneering research and technology paving the way for better clinical testing and patient care. From July 30–August 3 in San Diego, the meeting will feature more than 200 talks on a broad range of timely healthcare topics. Highlights of these include plenaries that explore transforming biology using CRISPR engineering and new applications for DNA sequencing; preserving fertility in young people with cancer; how clinical testing can help solve public health crises; and a session that uncovers the precision diagnostics that are creating a digital health revolution.
Press can register here to livestream this special session through Newswise Live on Monday, July 31 at 7:30 PM EDT. The winner of the Qualcomm Tricorder XPRIZE competition will present DxtER—a real-life tricorder—at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo in San Diego. This special session will be the first time that the device is presented to researchers at a U.S. scientific conference.
The NEFA assay from Wako Diagnostics is designed to detect a variety of non-esterified fatty acids (NEFA). The test is specific to free fatty acids with minimal interferences from other related compounds and serum components such as bilirubin, hemoglobin, and ascorbic acid. The need for an extraction step has been eliminated. The company’s enzymatic method relies upon the acylation of coenzyme A and ultimately results in a purple colored product that can be measured colorimetrically at 550 nm.
The Autokit CH50 assay from Wako Diagnostics is a fully automated liposome – based assay for the determination of total complement activity in human serum. This proven and widely used methodology can be applied to most automated chemistry analyzers to evaluate deficiency or abnormalities of the complement system. The homogenous size of liposomes gives a stable dispersion. This, along with a fast, 10 minute total reaction time and ease of use makes it the best choice for your lab.
SynAbs is proud to appoint LuBioSience as its new distributor for Switzerland. LuBioScience has a seasoned team and expertise in selling biochemicals, including the specific monoclonal antibodies of SynAbs, in particular the anti-species which should be welcomed by the Swiss Biopharma R&D and IVD sector.
RARITAN, N.J. – July 21, 2017 – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that Ortho’s VITROS® Immunodiagnostic Products Insulin Reagent and Calibrators have received CE Mark, broadening Ortho’s menu of tests that manage all aspects of diabetes and other pancreatic disorders. An important biomarker in diabetes and pre-diabetes testing, the assay is expected to be commercially available for use on all of Ortho’s VITROS® Immunodiagnostic and Integrated Systems in Europe and other countries accepting the CE Mark during the third quarter of this year.
According to the World Health Organization; diabetes affects nine percent of people 18 years or older worldwide.i What’s more, 191 million people with diabetes are currently undiagnosed.ii Diabetes is managed as a chronic, lifelong condition with several significant co-morbidities, so it is vital that laboratories have a partner that supports the continuum of diabetes diagnostics.
“Our goal
Uniflex- Healthcare Packaging, a division of the Uniflex/ S.Walter Packaging company has announced it will be returning to the the AACC 2017 meeting in San Diego, California during July 31-August 3rd, 2017. They will be located at booth 519 at the San Diego Convention Center during the annual meeting. Uniflex has historically been an industry leader and supplier of medical packaging products for 50+ years, and introduced to the market place the liquid-tight adhesive seal specimen bag, the UniVault (R) patient valuables bags, and recently launched its new Lab Shield (R) "Removable-Biohazard" specimen bag. Much excitement surrounds this new product line!
Monoclonal antibodies development has been limited for a long time to only two species : mice and rats. However, the immune systems of mice and rats are not the most suitable in terms of humoral response to certain antigens, such as human antigens like glucagon. Indeed, the protein sequence of glucagon is the same in mice, rats and human (fig. 1). Small not immunogenic antigens, such as antibiotics or toxins, generally failed to trigger an immune response in such species. This is why some companies have developed fusion cell lines to generate monoclonal antibodies in rabbit (Abcam-Epitomics) or in sheep (Bioventix). However, these two tools are not totally satisfactory whether in terms of cost, stability or productivity.
RSS